2023
B-50 | Full-Body Embolic Protection During Transcatheter Aortic Valve Replacement: The Protect the Head-to-Head Study, a Pivotal, Randomized Study Comparing the Emboliner Embolic Protection Catheter to the Sentinel CPS
Lansky A. B-50 | Full-Body Embolic Protection During Transcatheter Aortic Valve Replacement: The Protect the Head-to-Head Study, a Pivotal, Randomized Study Comparing the Emboliner Embolic Protection Catheter to the Sentinel CPS. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 100772. DOI: 10.1016/j.jscai.2023.100772.Peer-Reviewed Original Research
2022
Chapter 30 The “nitinol-constrained” Chocolate balloon angioplasty: clinical applications in patients with severe atherosclerotic peripheral arterial disease
Binyamin G, Gaston S, Konstantino E, Konstantino M, Lansky A. Chapter 30 The “nitinol-constrained” Chocolate balloon angioplasty: clinical applications in patients with severe atherosclerotic peripheral arterial disease. 2022, 673-688. DOI: 10.1016/b978-0-12-821451-0.00006-9.Peer-Reviewed Original ResearchPeripheral arterial diseaseAtherosclerotic peripheral arterial diseaseArterial diseaseBalloon angioplastyRevascularization strategyImpaired perfusionClinical syndromeBalloon catheterInvasive treatmentAngioplastyAngioplasty devicesDiseaseClinical applicationStentingPatientsCatheterSyndromePerfusionMainstay
2019
First-in-Human Study of Paclitaxel Drug-Coated Chocolate Coronary Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in De Novo Coronary Artery Lesions
Garcia-Lithgow C, Tirziu D, Zhou S, Bouras G, Shah T, Grubman D, Javier JJ, Mustapha JA, Abizaid A, Lansky AJ. First-in-Human Study of Paclitaxel Drug-Coated Chocolate Coronary Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in De Novo Coronary Artery Lesions. JACC Cardiovascular Interventions 2019, 12: 2568-2570. PMID: 31857033, DOI: 10.1016/j.jcin.2019.08.044.Peer-Reviewed Original Research
2017
TCT-640 24 Month Results From a First-In-Human Data on the Paclitaxel Drug-Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions
Bouras G, Abizaid A, Lithgow C, Cristea E, Lansky A. TCT-640 24 Month Results From a First-In-Human Data on the Paclitaxel Drug-Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions. Journal Of The American College Of Cardiology 2017, 70: b282. DOI: 10.1016/j.jacc.2017.09.889.Peer-Reviewed Original Research
2006
Final results from the multi-center trial of the angiosculpt scoring balloon catheter for the treatment of complex coronary artery lesions
Costa R, Mooney M, Teirstein P, Moses J, Turco M, Reisman M, Waksman R, Saucedo J, Mauri L, Lee D, Gershony G, Mehran R, Mintz G, Carlier S, Costa J, Cristea E, Dangas G, Lansky A, Leon M. Final results from the multi-center trial of the angiosculpt scoring balloon catheter for the treatment of complex coronary artery lesions. Cardiovascular Revascularization Medicine 2006, 7: 112. DOI: 10.1016/j.carrev.2006.03.068.Peer-Reviewed Original Research